Headache: The Journal of Head and Face Pain最新文献_第10页

Serum Vitamin B12 and Methylmalonic Acid Status in Migraineurs: A Case‐Control Study 偏头痛患者血清维生素B12和甲基丙二酸水平:一项病例对照研究

Headache: The Journal of Head and Face Pain Pub Date : 2019-10-01 DOI: 10.1111/head.13618

M. Togha, Soodeh Razeghi Jahromi, Zeinab Ghorbani, Fahimeh Martami, Maryam Seifishahpar

引用次数: 12

Trigeminal‐Targeted Treatments in Migraine: Is 60% the Magic Number? 偏头痛的三叉神经靶向治疗:60%是神奇的数字吗?

Headache: The Journal of Head and Face Pain Pub Date : 2019-10-01 DOI: 10.1111/head.13635

P. Barbanti, G. Egeo, D. Mitsikostas

引用次数: 9

The Impact of Shift Work on Migraine: A Case Series and Narrative Review 轮班工作对偏头痛的影响:一个案例系列和叙述回顾

Headache: The Journal of Head and Face Pain Pub Date : 2019-10-01 DOI: 10.1111/head.13622

Claire H Sandoe, S. Sasikumar, C. Lay, Valerie Lawler

引用次数: 21

What is Needed for Evidence‐Based Dietary Recommendations for Migraine: A Call to Action for Nutrition and Microbiome Research 偏头痛的循证饮食建议需要什么:营养和微生物组研究的行动呼吁

Headache: The Journal of Head and Face Pain Pub Date : 2019-10-01 DOI: 10.1111/head.13658

M. Slavin, Huilun Li, C. Frankenfeld, LawrenceJ Cheskin

引用次数: 18

Veracity in the Review Process 审核过程中的准确性

Headache: The Journal of Head and Face Pain Pub Date : 2019-10-01 DOI: 10.1111/head.13671

J. D. de Ru, T. Ward, J. Roberts

引用次数: 0

Triptans for Migraine Patients With Vascular Risks: New Insights, New Options 曲坦类药物用于有血管风险的偏头痛患者:新的见解，新的选择

Headache: The Journal of Head and Face Pain Pub Date : 2019-10-01 DOI: 10.1111/head.13656

E. Leroux, J. Rothrock

{"title":"Triptans for Migraine Patients With Vascular Risks: New Insights, New Options","authors":"E. Leroux, J. Rothrock","doi":"10.1111/head.13656","DOIUrl":"https://doi.org/10.1111/head.13656","url":null,"abstract":"Triptans remain a first-line therapy for acute migraine. Even 25 years after the commercialization of sumatriptan, clinicians still face challenges related to prescribing triptans for patients with cardiovascular risk factors or events. Our understanding of migraine and the triptans vis-a-vis cardiovascular risk factors and arterial physiology has evolved, but has this more detailed knowledge led to any meaningful change in clinical management? Case 1: Cardiovascular Risk Factors.—A 56-year-old male is sent to you for assessment of migraine without aura. He has a history of diabetes, hypertension, and smoking. He is using naproxen with partial success but still endures disabling attacks. Would you prescribe a triptan to this patient? How could you quantify his risk? Should he keep using naproxen? Case 2: Ischemic Stroke.—A 37-year-old woman presents with a history of migraine with aura since childhood. She reports a right anterior cerebral artery distribution ischemic stroke in the context of a cervical artery dissection 5 years ago. A CT scan of the brain with angiogram confirmed complete recanalization of the carotid artery, and she recovered fully from her symptoms. Non-steroidal anti-inflammatory drugs are not effective for her acute headaches, and she tried her sister's eletriptan with great success. Are you willing to prescribe eletriptan to her? Questions:","PeriodicalId":12845,"journal":{"name":"Headache: The Journal of Head and Face Pain","volume":"6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90351523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 9

Prolonged Postictal Coma in Hemiplegic Migraine: A Case Report 偏瘫性偏头痛后昏迷延长1例

Headache: The Journal of Head and Face Pain Pub Date : 2019-10-01 DOI: 10.1111/head.13606

Ian J. McClain, M. Tsai, Charles F. Guardia

{"title":"Prolonged Postictal Coma in Hemiplegic Migraine: A Case Report","authors":"Ian J. McClain, M. Tsai, Charles F. Guardia","doi":"10.1111/head.13606","DOIUrl":"https://doi.org/10.1111/head.13606","url":null,"abstract":"Familial hemiplegic migraine (FHM) is a rare disease characterized by episodes of a prominent motor aura manifesting as hemiparesis and often accompanied by ataxia, nystagmus, seizures, and varying degrees of altered consciousness. Patients with FHM may also experience coma and subsequent respiratory failure requiring intubation. We describe a 57-year-old man with a past medical history of FHM type 1 (FHM1), genetically proven CACNA1A carrier, prior alcohol withdrawal seizure and type 2 diabetes who presented after a witnessed generalized tonic-clonic seizure. Since the onset of this seizure, the patient remained unresponsive for ~4 minutes but ultimately required intubation for airway protection. Exam revealed normal pupillary responses, no meningeal signs, a tonic downward gaze with ocular dipping, and mute plantar reflexes. MRI of the brain was without acute diffusional abnormality and EEG revealed generalized theta and delta without epileptiform discharges. This likely represented an exacerbation of his underlying hemiplegic migraine. He was started on dexamethasone, levetiracetam, and his acetazolamide was continued. He was extubated and remained encephalopathic for 4 days, but motor function and sensation were unimpaired. Lamotrigine was ultimately started and his levetiracetam discontinued. He had 3 prior episodes of unilateral weakness followed by loss of consciousness starting his teenage years. Two years prior he was admitted following a convulsion and loss of consciousness and required intubation for airway support. MRI of the brain was normal and CSF analysis revealed a lymphocytic pleocytosis. EEG was without epileptiform abnormalities but revealed generalized theta. He was extubated and placed on acetazolamide. Family history disclosed a paternal uncle with hemiplegic migraines. FHM exists in different subtypes, each with an autosomal dominant, channelopathy related pathophysiology. FMH1 is caused by a mutation in the Headache doi: 10.1111/head.13606 © 2019 American Headache Society Published by Wiley Periodicals, Inc. ISSN 0017-8748","PeriodicalId":12845,"journal":{"name":"Headache: The Journal of Head and Face Pain","volume":"50 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83994197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Clinical Subtypes of Medication Overuse Headache – Findings From a Large Cohort 药物过度使用头痛的临床亚型——来自一个大队列的发现

Headache: The Journal of Head and Face Pain Pub Date : 2019-10-01 DOI: 10.1111/head.13641

M. Viana, R. De Icco, M. Allena, G. Sances, Jensen Rigmor Højland, Z. Katsarava, M. Láinez, R. Fadic, M. Goicochea, G. Nappi, C. Tassorelli

引用次数: 15

The American Headache Society Early Career Award 美国头痛协会早期职业奖

Headache: The Journal of Head and Face Pain Pub Date : 2019-10-01 DOI: 10.1111/head.13680

Jason Roberts

引用次数: 0

Dysautonomia and Headache in the Pediatric Population 儿科人群中的自主神经异常和头痛

Headache: The Journal of Head and Face Pain Pub Date : 2019-10-01 DOI: 10.1111/head.13659

Rebecca Wig, Christopher B. Oakley

{"title":"Dysautonomia and Headache in the Pediatric Population","authors":"Rebecca Wig, Christopher B. Oakley","doi":"10.1111/head.13659","DOIUrl":"https://doi.org/10.1111/head.13659","url":null,"abstract":"Dysautonomia and headache are 2 common diagnoses within pediatric neurology; in the case of dysautonomia, a lack of consideration may lead to misdiagnosis. Despite being common conditions, there is a lot to learn about each individually as well as collectively. Many of the symptoms between headache and dysautonomia patients overlap making the diagnosis difficult. Migraine patients often exhibit symptoms of dysautonomia, namely postural orthostatic tachycardia syndrome (POTS); yet these symptoms are overlooked or lumped in as a part of their migraine diagnosis. The distinction or coexistence between dysautonomia and headache is identified through a thorough history, a full exam, and an open mind. This is crucial for the treatment and outcomes of these patients. Struggles arise when critical treatment differences are overlooked because dysautonomia is not considered. In this review, we will look at the epidemiology of dysautonomia and headache with focus on POTS and migraine. We will then compare the clinical features of both conditions as well as some hypothesized pathophysiology overlaps. We will conclude by summarizing the diagnostic approach and multitiered treatment options for POTS and migraine.","PeriodicalId":12845,"journal":{"name":"Headache: The Journal of Head and Face Pain","volume":"21 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83985975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 4